Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens

Clinical Immunology

Volumn 127, Issue 3, 2008, Pages 366-374

  Hirai, Hiroki ^a   Miura, Junnosuke ^a   Hu, Yafang ^a   Larsson, Helena ^b   Larsson, Karin ^b   Lernmark, Ake ^c   Ivarsson, Sten A ^b   Wu, Tianxia ^a   Kingman, Albert ^a   Tzioufas, Athanasios G ^a   Notkins, Abner L ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoantibodies; Autoantigens; GAD65; IA 2; Protein tyrosine phosphatase; Proteome; Secretory vesicles; Type 1 diabetes

Indexed keywords

ALPHA FODRIN; AMPHIPHYSIN; AUTOANTIBODY; AUTOANTIGEN; BETA1 INTEGRIN; BETA2 SYNTROPHIN; CARBOXYPEPTIDASE; CHROMOGRANIN A; FURIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOKINASE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE TRANSPORTER 4; GLUTAMATE DECARBOXYLASE 65; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 70; INSULIN; NEUROPEPTIDE Y; PADGEM PROTEIN; PROTEIN IA 2; PROTEIN IA 2BETA; PROTEIN TYROSINE PHOSPHATASE ALPHA; PROTEOME; RAB11 PROTEIN; SYNAPTOBREVIN 2; SYNTAXIN 1A; SYNTAXIN 3A; SYNTAXIN 6; TRANSCRIPTION FACTOR JUNB; UNINDEXED DRUG;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SECRETORY VESICLE; SYNAPSE VESICLE; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; NEUROPEPTIDE Y; SECRETORY VESICLES; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2;

EID: 45249111131     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.018     Document Type: Article

References (42)

1. In: Notkins A.L., Lernmark A., and Leslie D. (Eds). Autoantibodies as Diagnostic and Predictive Markers of Autoimmune Diseases. Autoimmunity 37 (2004) 251-368
2. Fathman C.G., Soares L., Chan S.M., and Utz P.J. An array of possibilities for the study of autoimmunity. Nature 435 (2005) 605-611
3. Lan M.S., Wasserfall C., Maclaren N.K., and Notkins A.L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6367-6370
4. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., and Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37 (1994) 344-350
5. Yu L., Robles D.T., Abiru N., Kaur P., Rewers M., Kelemen K., and Eisenbarth G.S. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1701-1706
6. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
7. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., and Gale E.A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46 (1997) 1701-1710
8. Kulmala P., Savola K., Petersen J.S., Vahasalo P., Karjalainen J., Lopponen T., Dyrberg T., Akerblom H.K., and Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J. Clin. Invest. 101 (1998) 327-336
9. Lu J., Li Q., Xie H., Chen Z.J., Borovitskaya A.E., Maclaren N.K., Notkins A.L., and Lan M.S. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2307-2311
10. Xie H., Zhang B., Matsumoto Y., Li Q., Notkins A.L., and Lan M.S. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined. J. Immunol. 159 (1997) 3662-3667
11. Tuomi T., Rowley M.J., Knowles W.J., Chen Q.Y., McAnally T., Zimmet P.Z., and Mackay I.R. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 71 (1994) 53-59
12. Bonifacio E., Genovese S., Braghi S., Bazzigaluppi E., Lampasona V., Bingley P.J., Rogge L., Pastore M.R., Bognetti E., Bottazzo G.F., Gale E.A., and Bosi E. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38 (1995) 816-822
13. Steinbrenner H., Lohmann T., Ostendorf B., Scherbaum W.A., and Seissler J. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes. Diabetologia 43 (2000) 1381-1384
14. Fida S., Myers M., Mackay I.R., Zimmet P.Z., Mohan V., Deepa R., and Rowley M.J. Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13. Diabetes Res. Clin. Pract. 52 (2001) 205-211
15. Torn C., Shtauvere-Brameus A., Sanjeevi C.B., and Landin-Olsson M. Increased autoantibodies to SOX13 in Swedish patients with type 1 diabetes. Ann. N.Y. Acad. Sci. 958 (2002) 218-223
16. Chang Y.H., Shiau M.Y., Tsai S.T., and Lan M.S. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients. Biochem. Biophys. Res. Commun. 320 (2004) 802-809
17. Arden S.D., Roep B.O., Neophytou P.I., Usac E.F., Duinkerken G., de Vries R.R., and Hutton J.C. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97 (1996) 551-561
18. Winer S., Tsui H., Lau A., Song A., Li X., Cheung R.K., Sampson A., Afifiyan F., Elford A., Jackowski G., Becker D.J., Santamaria P., Ohashi P., and Dosch H.M. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat. Med. 9 (2003) 198-205
19. Yang J., Danke N.A., Berger D., Reichstetter S., Reijonen H., Greenbaum C., Pihoker C., James E.A., and Kwok W.W. Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J. Immunol. 176 (2006) 2781-2789
20. DeAizpurua H.J., Honeyman M.C., and Harrison L.C. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun. 5 (1992) 759-770
21. Honeyman M.C., Cram D.S., and Harrison L.C. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 42 (1993) 626-630
22. Roep B.O., Duinkerken G., Schreuder G.M., Kolb H., de Vries R.R., and Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 26 (1996) 1285-1289
23. Abulafia-Lapid R., Gillis D., Yosef O., Atlan H., and Cohen I.R. T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J. Autoimmun. 20 (2003) 313-321
24. Dotta F., Falorni A., Tiberti C., Dionisi S., Anastasi E., Torresi P., Lernmark A., and Di Mario U. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset. J. Autoimmun. 10 (1997) 585-588
25. Schranz D.B., and Lernmark A. Immunology in diabetes: an update. Diabetes Metab. Rev. 14 (1998) 3-29
26. Solimena M. Vesicular autoantigens of type 1 diabetes. Diabetes Metab. Rev. 14 (1998) 227-240
27. Pehuet-Figoni M., Alvarez F., Bach J.F., and Chatenoud L. Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucose transporter. Clin. Exp. Immunol. 122 (2000) 164-169
28. Winnock F., Christie M.R., Batstra M.R., Aanstoot H.J., Weets I., Decochez K., Jopart P., Nicolaij D., and Gorus F.K. Belgian Diabetes Registry, Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies. Diabetes Care 24 (2001) 1181-1186
29. Andersson K., Buschard K., Fredman P., Kaas A., Lidstrom A.M., Madsbad S., Mortensen H., and Jan-Eric M. Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay. Autoimmunity 35 (2002) 463-468
30. Shervani N.J., Takasawa S., Uchigata Y., Akiyama T., Nakagawa K., Noguchi N., Takada H., Takahashi I., Yamauchi A., Ikeda T., Iwamoto Y., Nata K., and Okamoto H. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients. Eur. J. Clin. Invest. 34 (2004) 752-758
31. Sordi V., Lampasona V., Cainarca S., and Bonifacio E. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation. Diabet. Med. 22 (2005) 1770-1773
32. Gorus F.K., Sodoyez J.C., Pipeleers D.G., Keymeulen B., Foriers A., and Van Schravendijk C.F. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry. Diabetologia 35 (1992) 1080-1086
33. Baumert M., Maycox P.R., Navone F., De Camilli P., and Jahn R. Synaptobrevin: an integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain. EMBO J. 8 (1989) 379-384
34. Chen Y.A., and Scheller R.H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2 (2001) 98-106
35. Adrian T.E., Allen J.M., Bloom S.R., Ghatei M.A., Rossor M.N., Roberts G.W., Crow T.J., Tatemoto K., and Polak J.M. Neuropeptide Y distribution in human brain. Nature 306 (1983) 584-586
36. Prod'homme T., Weber M.S., Steinman L., and Zamvil S.S. A neuropeptide in immune-mediated inflammation, Y?. Trends Immunol. 27 (2006) 164-167
37. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., and Hutton J.C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17040-17045
38. Drell D.W., and Notkins A.L. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30 (1987) 132-143
39. Lieberman S.M., and DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62 (2003) 359-377
40. Mansson L., Torn C., and Landin-Olsson M. Islet cell antibodies represent autoimmune response against several antigens. Int. J. Exp. Diabetes Res. 2 (2001) 85-90
41. Borg H., Fernlund P., and Sundkvist G. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin. Chem. 43 (1997) 2358-2363
42. Kupila A., Keskinen P., Simell T., Erkkila S., Arvilommi P., Korhonen S., Kimpimaki T., Sjoroos M., Ronkainen M., Ilonen J., Knip M., and Simell O. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 51 (2002) 646-651